Capricor sues Nippon Shinyaku over Duchenne drug 'pricing flaw' and launch prep

May 8, 2026 07:00 AM EDT PharmaLaw Capri­cor sues Nip­pon Shinyaku over Duchenne drug 'pric­ing flaw' and launch prep Ayisha Sharma News Reporter Capri­cor Ther­a­peu­tics said Thurs­day it has filed a law­suit against Nip­pon Shinyaku over a dis­tri­b­u­tion and com­mer­cial­iza­tion agree­ment for de­ramio­cel, a cell ther­a­py can­di­date for … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER